Cell name:
MV-4-11(systemic)
Other names for the model:
MV4-11、MV-4:11、MV4:11、MV 4;11、MV4;11、MV411、MV(4;11)、MV4II
Cell information:
MV-4-11 cells are derived from human myeloid leukemia cells and are used for screening multiple target inhibitors, such as FLT3. Click to viewMore information.
Model information:
Inoculate the tail vein, and the mouse strain is NOD/SCID. Approximately 7 days after vaccination can be grouped, and the administration time after grouping is approximately 21 days.Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059
Email: BD@truwaybio.com
Business: +86 185-0139-0702
Technology: +86 137-7300-5709
Website Usage Help: +86 188-6238-7270
Landline: +86 0512-80601059